Literature DB >> 10030241

Patulous eustachian tube in long-term survivors of nasopharyngeal carcinoma.

P W Cheng1, Y H Young, P J Lou.   

Abstract

This article reports on 21 long-term (10 years) survivors of nasopharyngeal carcinoma, divided into 2 groups: those subjected to an inflation-deflation test and a clearance function test in a longitudinal study, and those receiving sonotubometry in a cross-sectional study. On the inflation-deflation test, 12 (55%) out of 22 ears had a patulous eustachian tube, and on sonotubometry, 10 (50%) out of 20 ears also revealed a patulous eustachian tube. Except for 4 ears with chronic otitis media, the ears had resolved to a normal eardrum appearance at 10 years postirradiation. The phenomenon might be attributed to both restoration of the impaired tubal function and the development of a patulous tube.

Entities:  

Mesh:

Year:  1999        PMID: 10030241     DOI: 10.1177/000348949910800217

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  4 in total

1.  [Diagnosis and treatment of Eustachian tube dysfunction].

Authors:  S Schröder; J Ebmeyer
Journal:  HNO       Date:  2018-02       Impact factor: 1.284

Review 2.  [The patulous eustachian tube-novel surgical approaches].

Authors:  S Schröder; M Lehmann; H Sudhoff; J Ebmeyer
Journal:  HNO       Date:  2013-12       Impact factor: 1.284

3.  Post-irradiation otitis media, rhinosinusitis, and their interrelationship in nasopharyngeal carcinoma patients treated by IMRT.

Authors:  Chung-Han Hsin; Hsien-Chun Tseng; Huang-Pin Lin; Tsai-Hsin Chen
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-01-30       Impact factor: 2.503

4.  Prospective study on the dose distribution to the acoustic structures during postoperative 3D conformal radiotherapy for parotid tumors: dosimetric and audiometric aspects.

Authors:  Barbara A Jereczek-Fossa; Elena Rondi; Andrzej Zarowski; Alberto D'Onofrio; Daniela Alterio; Mario Ciocca; Livia Corinna Bianchi; Marco Krengli; Luca Calabrese; Mohssen Ansarin; Gioacchino Giugliano; Roberto Orecchia
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.